Drug Executive Is Indicted on Secret Deal

April 23rd, 2008 at 11:30 pm (Apotex Inc, Bodnar, Andrew G, Bristol-Myers Squibb Co|BMY|NYSE, Drugs (Pharmaceuticals), Federal Trade Commission, Generic and Brand Name Products, Plavix (Drug), Suits and Litigation)

A former Bristol-Myers Squibb executive was charged with making false statements to the F.T.C. about a pact made with a Canadian maker of generic drugs.

Zrodlo (oryginalny wpis) na http://www.nytimes.com/2008/04/24/business/24bristol.html?ex=1366776000&en=d2674a18571b0fd7&ei=5088&partner=rssnyt&emc=rss,By STEPHANIE SAUL

Comments

AstraZeneca in Pact With Rival to Delay a Generic Drug

April 15th, 2008 at 6:00 pm (AstraZeneca|AZN|NYSE, Drugs (Pharmaceuticals), Food and Drug Administration, Generic and Brand Name Products, India, Nexium, Ranbaxy Laboratories)

Shares in the drugmaker soared on news that it reached a deal with an Indian company, delaying the release of a generic competitor to its heartburn drug Nexium.

Zrodlo (oryginalny wpis) na http://www.nytimes.com/2008/04/16/business/16drug.html?ex=1366084800&en=bcd655782156511e&ei=5088&partner=rssnyt&emc=rss,By THE ASSOCIATED PRESS

Comments